The neutrophil–lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials by Kumar, R, Geuna, E, Michalarea, V, Guardascione, M, Naumann, U, Lorente, D, Kaye, S B, de Bono, J S

Get full text

EXCELLENT OUTCOMES USING RITUXIMAB, GEMCITABINE, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISOLONE (R‐GCVP) IN PATIENTS WITH DLBCL AND CARDIAC COMORBIDITIES by Michalarea, V., Low, R., Kirkwood, A.A., Harrington, P., Yadollahi, S., Djebbari, F., Gleeson, M., Cwynarski, K., Lambert, J., Chau, I., Wrench, D., Eyre, T.A., Davies, A., Ardeshna, K.M., Cunningham, D., Fields, P.

Get full text

339 Clinical outcome and prognostic factors of patients (pts) with relapsed mesothelioma on phase I trials in the Drug Development Unit (DDU) of the Royal Marsden Hospital (RMH) by Papadatos-Pastos, D, Roda, D, Luken, M. De Miguel, Jalil, A, Diamantis, N, Michalarea, V, Lima, J, Capelan, M, Bodla, S, Bhosle, J, Molife, R, O'Brien, M, Banerji, U, Popat, S, Yap, T

Get full text

343 Translational phase I trial combining the AKT inhibitor AZD5363 (AZD) and PARP inhibitor Olaparib (Ola) in advanced cancer patients (pts) by Michalarea, V, Lopez, J, Lorente, D, Carreira, S, Hassam, H, Parmar, M, Turner, A, Hall, E, Fandos, S. Serrano, Decordova, S, Swales, K, Ruddle, R, Raynaud, F, Tunariu, N, Stephens, C.M, Molife, L.R, Banerji, U, Plummer, R, Bono, J. De, Yap, T.A

Get full text

129 Treating non small cell lung cancer with erlotinib: the Nurse Led clinic experience by Compton, S, Michalarea, V, Pintus, E, Thomas, R, Colvin, M, Tindale-Paul, P, Eestila, S, Montes, A, Spicer, J, Lal, R

Get full text

Abstract P2-01-13: Can axillary lymph node clearance be avoided in women with node positive breast cancer receiving primary chemotherapy? by Chowdhury, MHR, Thillai, K, Lucey, A, Michalarea, V, Mera, A, Karapanagiotou, E, Sandri, I, Mansi, J

Get full text

Abstract P3-17-09: Resolution of DCIS in patients with early breast cancer receiving primary chemotherapy for invasive breast cancer by Chowdhury, MHR, Thillai, K, Lucey, A, Michalarea, V, Mera, A, Karapanagiotou, E, Sandri, I, Mansi, J

Get full text

353 (PB-148) - Does primary chemotherapy play a role in treating DCIS in women with high risk early breast invasive carcinoma? by Germanou, S.E., Chowdhury, M.R., Thillai, K., Lucey, A., Michalarea, V., Mera, A., Karapanagiotou, E., Sandri, I., Mansi, J.

Get full text

Does primary chemotherapy play a role in treating DCIS in women with high risk early breast invasive carcinoma? by Germanou, S.E., Chowdhury, M.R., Thillai, K., Lucey, A., Michalarea, V., Mera, A., Karapanagiotou, E., Sandri, I., Mansi, J.

Get full text

Could Women with Biopsy Proven Lymph Node Positive Breast Cancer and Response to Primary Chemotherapy Avoid Axillary Lymph Node Clearance? by Germanou, S., Ruhe Chowdhury, M.H., Thillai, K., Lucey, A., Michalarea, V., Mera, A., Karapanagiotou, E., Sandri, I., Mansi, J.

Get full text

Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage by Carotenuto, Pietro, Amato, Francesco, Lampis, Andrea, Rae, Colin, Hedayat, Somaieh, Previdi, Maria C., Zito, Domenico, Raj, Maya, Guzzardo, Vincenza, Sclafani, Francesco, Lanese, Andrea, Parisi, Claudia, Vicentini, Caterina, Said-Huntingford, Ian, Hahne, Jens C., Hallsworth, Albert, Kirkin, Vladimir, Young, Kate, Begum, Ruwaida, Wotherspoon, Andrew, Kouvelakis, Kyriakos, Azevedo, Sergio Xavier, Michalarea, Vasiliki, Upstill-Goddard, Rosie, Rao, Sheela, Watkins, David, Starling, Naureen, Sadanandam, Anguraj, Chang, David K., Biankin, Andrew V., Jamieson, Nigel B., Scarpa, Aldo, Cunningham, David, Chau, Ian, Workman, Paul, Fassan, Matteo, Valeri, Nicola, Braconi, Chiara

Get full text